22 related articles for article (PubMed ID: 17235971)
1. Liver cancer antiproliferative activity of a new nor-cucurbitacin from Mareya micrantha Müll. Arg.
Toussaint-Douhoré GY; Soro Y; Ouédraogo N; Vaca-Garcia C; Koffi-Attioua B; Carraz M
Fitoterapia; 2023 Apr; 166():105471. PubMed ID: 36918040
[TBL] [Abstract][Full Text] [Related]
2. Mass Spectrometric Analysis of Cucurbitacins and Dihydrocucurbitacins from the Tuber of
Benka M; Görlitz K; Schöttgen MC; Lagies S; Mohl DA; Kather M; Du Preez-Bruwer I; Mumbengegwi D; Teufel R; Kowarschik S; Huber R; Plattner DA; Kammerer B
Biomolecules; 2023 Jul; 13(8):. PubMed ID: 37627233
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in the Application of Cucurbitacins as Anticancer Agents.
Zieniuk B; Pawełkowicz M
Metabolites; 2023 Oct; 13(10):. PubMed ID: 37887406
[TBL] [Abstract][Full Text] [Related]
4. Cucurbitacin B Inhibits the Hippo-YAP Signaling Pathway and Exerts Anticancer Activity in Colorectal Cancer Cells.
Chai Y; Xiang K; Wu Y; Zhang T; Liu Y; Liu X; Zhen W; Si Y
Med Sci Monit; 2018 Dec; 24():9251-9258. PubMed ID: 30566960
[TBL] [Abstract][Full Text] [Related]
5. Cucurbitacin B inhibits cell proliferation and induces apoptosis in human osteosarcoma cells via modulation of the JAK2/STAT3 and MAPK pathways.
Zhang ZR; Gao MX; Yang K
Exp Ther Med; 2017 Jul; 14(1):805-812. PubMed ID: 28673003
[TBL] [Abstract][Full Text] [Related]
6. Cucurbitacin D exhibits potent anti-cancer activity in cervical cancer.
Sikander M; Hafeez BB; Malik S; Alsayari A; Halaweish FT; Yallapu MM; Chauhan SC; Jaggi M
Sci Rep; 2016 Nov; 6():36594. PubMed ID: 27824155
[TBL] [Abstract][Full Text] [Related]
7. The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.
Promkan M; Dakeng S; Chakrabarty S; Bögler O; Patmasiriwat P
PLoS One; 2013; 8(2):e55732. PubMed ID: 23393598
[TBL] [Abstract][Full Text] [Related]
8. Cucurbitacin B Causes Increased Radiation Sensitivity of Human Breast Cancer Cells via G2/M Cell Cycle Arrest.
Duangmano S; Sae-Lim P; Suksamrarn A; Patmasiriwat P; Domann FE
J Oncol; 2012; 2012():601682. PubMed ID: 22690217
[TBL] [Abstract][Full Text] [Related]
9. [Studies on the constituents of trichosanthes root. III. Constituents of roots of Trichosanthes bracteata Voigt].
Kitajima J; Mukai A; Masuda Y; Tanaka Y
Yakugaku Zasshi; 1989 Apr; 109(4):265-70. PubMed ID: 2760813
[TBL] [Abstract][Full Text] [Related]
10. Cucurbitacins as Constituents of Wilbrandia ebracteata.
Farias MR; Schenkel EP; Mayer R; Rücker G
Planta Med; 1993 Jun; 59(3):272-5. PubMed ID: 17235971
[TBL] [Abstract][Full Text] [Related]
11. New cucurbitacin glycosides from Picrorhiza kurrooa.
Stuppner H; Wagner H
Planta Med; 1989 Dec; 55(6):559-63. PubMed ID: 2616673
[TBL] [Abstract][Full Text] [Related]
12. New cytotoxic cucurbitacins from Wilbrandia ebracteata Cogn.
Lang KL; da Rosa Guimarães T; Rocha Machado V; Zimmermann LA; Silva IT; Teixeira MR; Durán FJ; Palermo JA; Simões CM; Caro MS; Schenkel EP
Planta Med; 2011 Sep; 77(14):1648-51. PubMed ID: 21472651
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory and analgesic effects of cucurbitacins from Wilbrandia ebracteata.
Peters RR; Farias MR; Ribeiro-do-Valle RM
Planta Med; 1997 Dec; 63(6):525-8. PubMed ID: 9434604
[TBL] [Abstract][Full Text] [Related]
14. Cucurbitacins from Cayaponia racemosa: isolation and total assignment of 1H and 13C NMR spectra.
Chaves DC; Assunção JC; Braz-Filho R; Lemos TL; Monte FJ
Magn Reson Chem; 2007 May; 45(5):389-92. PubMed ID: 17372957
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
